Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesInterest Income - NetNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Guided Therapeutics (GTHP) Interest Income - Total (2023 - 2024)

Guided Therapeutics' Interest Income - Total history spans 2 years, with the latest figure at $3000.0 for Q1 2024.

  • On a quarterly basis, Interest Income - Total changed N/A to $3000.0 in Q1 2024 year-over-year; TTM through Dec 2024 was $3000.0, a 50.0% decrease, with the full-year FY2024 number at $3000.0, down 50.0% from a year prior.
  • Interest Income - Total hit $3000.0 in Q1 2024 for Guided Therapeutics, down from $6000.0 in the prior quarter.
  • Over the last five years, Interest Income - Total for GTHP hit a ceiling of $6000.0 in Q4 2023 and a floor of $3000.0 in Q1 2024.